BioRestorative Therapies, Inc. (BRTX) Form 8-K — Aug 25, 2026
BioRestorative Therapies received a delinquency notification letter from Nasdaq's Listing Qualifications Department on August 21, 2026, because it failed to timely file its Form 10-Q for the quarter ended June 30, 2026. The company is now out of compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all periodic financial reports. The notice has no immediate effect on the listing — BRTX common stock continues to trade on the Nasdaq Capital Market — and the company has until October 20, 2026, to submit a plan to regain compliance.
Key figures
- Nasdaq Rule
- Listing Rule 5250(c)(1)
- Delinquent Filing
- Form 10-Q for quarterly period ended June 30, 2026
- Exception Period Days
- 180
- Compliance Plan Deadline
- October 20, 2026
- Max Regain Compliance Deadline
- February 16, 2027
Price after filing
Close on the filing date to close N calendar days later (from $0.21). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.